Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{194786,
        author = {Dr. Sivakumar Dande},
        title = {Effect of Jalukavcharan in the Managemant of Puyalasa (Acute Dacryocystitis )},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {10},
        pages = {6306-6309},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=194786},
        abstract = {Background: Puyalasa is described in classical Ayurvedic texts as a suppurative inflammatory condition occurring at the inner canthus of the eye, characterized by swelling, pain, and purulent discharge. It can be clinically correlated with Acute Dacryocystitis, a persistent infection of the lacrimal sac commonly resulting from nasolacrimal duct obstruction. Conventional management primarily includes antibiotics and surgical intervention; however, recurrence and post-surgical complications remain concerns. In Ayurveda, localized inflammatory conditions involving vitiation of Pitta and Rakta are effectively managed through Raktamokshana, particularly Jalaukavacharana.Objective To evaluate the clinical efficacy of Jalaukavacharana in the management of Pualasa (Acute Dacryocystitis). Case PresentationA 26-year-old female presented with complaints of epiphora, mucopurulent discharge, tenderness, and swelling over the lacrimal sac region for six months. Based on clinical findings and Ayurvedic assessment, the condition was diagnosed as Puyalasa.Intervention Jalaukavacharana was performed locally over the lacrimal sac region in three sittings at weekly intervals, following proper procedural guidelines of Raktamokshana. Results Significant improvement was observed in swelling, tenderness, and purulent discharge. Lacrimal sac regurgitation reduced markedly, indicating improved drainage and reduction of local inflammation. Conclusion The study suggests that Jalaukavacharana may serve as a safe and minimally invasive therapeutic option in the management of Puyalasa. Its anti-inflammatory and microcirculatory enhancing effects may contribute to clinical improvement. Further large-scale studies are warranted to substantiate these findings.},
        keywords = {Jalaukavacharana, Puyalasa, Raktamokshana, Acute Dacryocystitis, Nasolacrimal Duct Obstruction},
        month = {March},
        }